Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Medshine Discovery patents Rho kinase inhibitors

Nov. 11, 2019

PARP degradation joins trapping, inhibition

Nov. 6, 2019

Dopamine goes from pleasure to repair molecule

Nov. 5, 2019

Rightsizing brain activity increases lifespan, but REST is not all good

Oct. 31, 2019

Blade Therapeutics identifies new calpain inhibitors

Oct. 23, 2019

Mitochondrial mutations hamper nuclear DNA repair

Oct. 14, 2019

Potent new small-molecule inhibitors block apoptosis in mice

Oct. 11, 2019

Calling bias sinks CCR5 work, but is "likely unique" to variant

Oct. 10, 2019

Three win Nobel for hypoxia work

Oct. 8, 2019

Aerie Pharmaceuticals synthesizes new kinase inhibitors

Oct. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.